- Home
- ACNT vs GALT Comparison
ACNT vs GALT Comparison
Compare ACNT & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACNT | GALT |
|---|---|---|
| Founded | 1945 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 176.7M |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ACNT | GALT |
|---|---|---|
| Price | $12.79 | $3.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 125.5K | ★ 311.9K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.72 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $143.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.62 | $1.15 |
| 52 Week High | $17.92 | $7.13 |
Technical Indicators
Market Signals| Indicator | ACNT | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 20.15 | 48.57 |
| Support Level | $12.08 | $2.88 |
| Resistance Level | $13.06 | $3.27 |
| Average True Range (ATR) | 0.60 | 0.24 |
| MACD | -0.44 | 0.03 |
| Stochastic Oscillator | 5.81 | 32.79 |
Price Performance
Historical ComparisonAbout ACNT Ascent Industries Co.
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.